Proinflammatory role of inducible nitric oxide synthase in acute hyperoxic lung injury

Respiratory Research

Volumn 5, Issue , 2004, Pages

  Hesse, Anne Karin ^a   Dörger, Martina ^a   Kupatt, Christian ^b   Krombach, Fritz ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LACTATE DEHYDROGENASE; MESSENGER RNA; OXYGEN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; IMMUNOLOGIC FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; HYPEROXIA; INFLAMMATION; KNOCKOUT MOUSE; LEUKOCYTE DIFFERENTIAL COUNT; LIPID PEROXIDATION; LUNG INJURY; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; OXYGEN TOXICITY; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; WILD TYPE; ACUTE DISEASE; ANIMAL; C57BL MOUSE; COMPARATIVE STUDY; ENZYMOLOGY; IMMUNOLOGY; LUNG; MOUSE MUTANT;

ACUTE DISEASE; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; HYPEROXIA; IMMUNOLOGIC FACTORS; LUNG; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 21344461563     PISSN: 1465993X     EISSN: None     Source Type: Journal    
DOI: 10.1186/1465-9921-5-11     Document Type: Article

References (56)

1. Carvalho CR, de Paula Pinto Schettino G, Maranhao B, Bethlem EP: Hyperoxia and lung disease. Curr Opin Pulm Med 1998, 4:300-304.
2. Bailey TC, Cavanagh C, Mehta S, Lewis JF, Veldhuizen RA: Sepsis and hyperoxia effects on the pulmonary surfactant system in wild-type and iNOS knockout mice. Eur Respir J 2002, 20:177-182.
3. Capellier G, Maupoil V, Boussat S, Laurent E, Neidhardt A: Oxygen toxicity and tolerance. Minerva Anestesiol 1999, 65:388-392.
4. Klein J: Normobaric pulmonary oxygen toxicity. Anesth Analg 1990, 70:195-207.
5. Chabot F, Mitchell JA, Gutteridge JM, Evans TW: Reactive oxygen species in acute lung injury. Eur Respir J 1998, 11:745-757.
6. Crapo JD, Tierney DF: Superoxide dismutase and pulmonary oxygen toxicity. Am J Physiol 1974, 226:1401-1407.
7. Stogner SW, Payne DK: Oxygen toxicity. Ann Pharmacother 1992, 26:1554-1562.
8. Feeney L, Berman ER: Oxygen toxicity: membrane damage by free radicals. Invest Ophthalmol 1976, 15:789-792.
9. Jamieson D, Chance B, Cadenas E, Boveris A: The relation of free radical production to hyperoxia. Annu Rev Physiol 1986, 48:703-719.
10. Turanlahti M, Pesonen E, Lassus P, Andersson S: Nitric oxide and hyperoxia in oxidative lung injury. Acta Paediatr 2000, 89:966-970.
11. Barazzone C, Tacchini-Cottier F, Vesin C, Rochat AF, Piguet PF: Hyperoxia induces platelet activation and lung sequestration: an event dependent on tumor necrosis factor-alpha and CD11a. Am J Respir Cell Mol Biol 1996, 15:107-114.
12. Ben-Ari J, Makhoul IR, Dorio RJ, Buckley S, Warburton D, Walker SM: Cytokine response during hyperoxia: sequential production of pulmonary tumor necrosis factor and interleukin-6 in neonatal rats. Isr Med Assoc J 2000, 2:365-369.
13. 2 toxicity: role of endogenous tumor necrosis factor. Exp Lung Res 1995, 21:589-597.
14. al-Ali MK, Howarth PH: Nitric oxide and the respiratory system in health and disease. Respir Med 1998, 92:701-715.
15. Kerwin JF Jr, Lancaster JR Jr, Feldman PL: Nitric oxide: a new paradigm for second messengers. J Med Chem 1995, 38:4343-4362.
16. Pryor WA, Squadrito GL: The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol 1995, 268:L699-L722.
17. Radi R, Beckman JS, Bush KM, Freeman BA: Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991, 288:481-487.
18. Lyons CR: The role of nitric oxide in inflammation. Adv Immunol 1995, 60:323-371.
19. Nathan C, Xie QW: Nitric oxide synthases: roles, tolls, and controls. Cell 1994, 78:915-918.
20. Gaston B, Drazen JM, Loscalzo J, Stamler JS: The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med 1994, 149:538-551.
21. Fischmann TO, Hruza A, Niu XD, Fossetta JD, Lunn CA, Dolphin E, Prongay AJ, Reichert P, Lundell DJ, Narula SK, Weber PC: Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation. Nat Struct Biol 1999, 6:233-242.
22. Schulz C, Gillissen A, Schultze-Werninghaus G: Inducible nitric oxide synthase in pulmonary inflammatory processes. Pneumologie 1998, 52:340-349.
23. Ermert M, Ruppert C, Gunther A, Duncker HR, Seeger W, Ermert L: Cell-specific nitric oxide synthase isoenzyme expression and regulation in response to endotoxin in intact rat lungs. Lab Invest 2002, 82:425-441.
24. Hickey MJ, Sharkey KA, Sihota EG, Reinhardt PH, MacMicking JD, Nathan C, Kubes P: Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia. FASEB J 1997, 11:955-964.
25. Hollenberg SM, Broussard M, Osman J, Parrillo JE: Increased microvascular reactivity and improved mortality in septic mice lacking inducible nitric oxide synthase. Circ Res 2000, 86:774-778.
26. Dorger M, Allmeling AM, Kiefmann R, Munzing S, Messmer K, Krombach F: Early inflammatory response to asbestos exposure in rat and hamster lungs: role of inducible nitric oxide synthase. Toxicol Appl Pharmacol 2002, 181:93-105.
27. Dorger M, Allmeling AM, Kiefmann R, Schropp A, Krombach F: Dual role of inducible nitric oxide synthase in acute asbestosinduced lung injury. Free Radic Biol Med 2002, 33:491-501.
28. Steudel W, Watanabe M, Dikranian K, Jacobson M, Jones RC: Expression of nitric oxide synthase isoforms (NOS II and NOS III) in adult rat lung in hyperoxic pulmonary hypertension. Cell Tissue Res 1999, 295:317-329.
29. Ermert M, Ruppert C, Gunther A, Duncker HR, Seeger W, Ermert L: Cell-specific nitric oxide synthase-isoenzyme expression and regulation in response to endotoxin in intact rat lungs. Lab Invest 2002, 82:425-441.
30. Cucchiaro G, Tatum AH, Brown MC, Camporesi EM, Daucher JW, Hakim TS: Inducible nitric oxide synthase in the lung and exhaled nitric oxide after hyperoxia. Am J Physiol 1999, 277:L636-L644.
31. Kobayashi H, Hataishi R, Mitsufuji H, Tanaka M, Jacobson M, Tomita T, Zapol WM, Jones RC: Antiinflammatory properties of inducible nitric oxide synthase in acute hyperoxic lung injury. Am J Respir Cell Mol Biol 2001, 24:390-397.
32. Arkovitz MS, Szabo C, Garcia VF, Wong HR, Wispe JR: Differential effects of hyperoxia on the inducible and constitutive isoforms of nitric oxide synthase in the lung. Shock 1997, 7:345-350.
33. Haddad IY, Zhu S, Crow J, Barefield E, Gadilhe T, Matalon S: Inhibition of alveolar type II cell ATP and surfactant synthesis by nitric oxide. Am J Physiol 1996, 270:L898-L906.
34. Pepperl S, Dorger M, Ringel F, Kupatt C, Krombach F: Hyperoxia upregulates the NO pathway in alveolar macrophages in vitro: role of AP-1 and NF-kappa B. Am J Physiol Lung Cell Mol Physiol 2001, 280:L905-L913.
35. Shea LM, Beehler C, Schwartz M, Shenkar R, Tuder R, Abraham E: Hyperoxia activates NF-kappaB and increases TNF-alpha and IFN-gamma gene expression in mouse pulmonary lymphocytes. J Immunol 1996, 157:3902-3908.
36. D'Angio CT, Finkelstein JN: Oxygen regulation of gene expression: a study in opposites. Mol Genet Metab 2000, 71:371-380.
37. Haddad JJ: Antioxidant and prooxidant mechanisms in the regulation of redox (Y)-sensitive transcription factors. Cell Signal 2002, 14:879-897.
38. Lee PJ, Choi AMK: Pathways of cell signaling in hyperoxia. Free Radic Biol Med 2003, 35:341-350.
39. Lowenstein CJ, Alley EW, Raval P, Snowman AM, Snyder SH, Russell SW, Murphy WJ: Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc Natl Acad Sci U S A 1993, 90:9730-9734.
40. Nunokawa Y, Oikawa S, Tanaka S: Human inducible nitric oxide synthase gene is transcriptionally regulated by nuclear factor-kappa B dependent mechanism. Biochem Biophys Res Commun 1996, 223:347-352.
41. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie QW, Sokol K, Hutchinson N, Chen H, Mudgett JS: Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995, 81:641-650.
42. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC: Measurement of protein using bicinchoninic acid. Anal Biochem 1985, 150:76-85.
43. Dignam JD, Lebovitz RM, Roeder RG: Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983, 11(1):475-1489.
44. Thiery J, Teupser D, Walli AK, Ivandic B, Nebendahl K, Stein O, Stein Y, Seidel D: Study of causes underlying the low atherosclerotic response to dietary hypercholesterolemia in a selected strain of rabbits. Atherosclerosis 1996, 121:63-73.
45. Dedhia HV, Ma JY, Vallyathan V, Dalal NS, Banks D, Flink EB, Billie M, Barger MW, Castranova V: Exposure of rats to hyperoxia: alteration of lavagate parameters and macrophage function. J Toxicol Environ Health 1993, 40:1-13.
46. Lefer DJ, Jones SP, Girod WG, Baines A, Grisham MB, Cockrell AS, Huang PL, Scalia R: Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice. Am J Physiol 1999, 276:H1943-H1950.
47. Auten RL, Whorton MH, Nicholas MS: Blocking neutrophil influx reduces DNA damage in hyperoxia-exposed newborn rat lung. Am J Respir Cell Mol Biol 2002, 26:391-397.
48. Kleeberger SR, Reddy SP, Zhang LY, Cho HY, Jedlicka AE: Toll-like receptor 4 mediates ozone-induced murine lung hyperpermeability via inducible nitric oxide synthase. Am J Physiol Lung Cell Mol Physiol 2001, 280:L326-L333.
49. Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, van der Vliet A: Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998, 391:393-397.
50. Kozlov AV, Sobhian B, Duvigneau C, Gemeiner M, Nohl H, Redl H, Bahrami S: Organ specific formation of nitrosyl complexes under intestinal ischemia/reperfusion in rats involves NOS-independent mechanism(s). Shock 2001, 15:366-371.
51. Desmarquest P, Chadelat K, Corroyer S, Cazals V, Clement A: Effect of hyperoxia on human macrophage cytokine response. Respir Med 1998, 92:951-960.
52. Horinouchi H, Wang CC, Shepherd KE, Jones R: TNF alpha gene and protein expression in alveolar macrophages in acute and chronic hyperoxia-induced lung injury. Am J Respir Cell Mol Biol 1996, 14:548-555.
53. Sass G, Koerber K, Bang R, Guehring H, Tiegs G: Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice. J Clin Invest 2001, 107:439-447.
54. Chen F, Kuhn DC, Sun SC, Gaydos LJ, Demers LM: Dependence and reversal of nitric oxide production on NF-kappa B in silica and lipopolysaccharide-induced macrophages. Biochem Biophys Res Commun 1995, 214:839-846.
55. Kupatt C, Weber C, Wolf A, Becker BF, Smith TW, Kelly RA: Nitric oxide attenuates reoxygenation-induced ICAM-1 expression in coronary microvascular endothelium: role of NF-kappa B. J Mol Cell Cardiol 1997, 29:2599-2609.
56. Janssen YM, Matalon S, Mossman BT: Differential induction of cfos, c-jun, and apoptosis in lung epithelial cells exposed to ROS or RNS. Am J Physiol 1997, 273:L789-L796.